Indomethacin Injection Market Owing to the Increasing Demand For the Drug in Osteoarthritis

According to Precision Business Insights (PBI) latest report, the indomethacin injection market size is expected to be worth USD 229.6 million in 2022, growing at a 7.6% CAGR from 2022 to 2028. One of the major factors driving the indomethacin injection market is the rising prevalence of osteoarthritis. Obesity and a high BMI are two factors that increase the chance of developing osteoarthritis. As a result of the expanding global prevalence of osteoarthritis, the demand for osteoarthritis therapies is increasing. Because of the rising frequency of various types of arthritis around the world, the market is rapidly expanding. Furthermore, the growing senior population in many countries around the world is driving up the demand for arthritis drugs. Furthermore, escalating sports injuries, which lead to a higher risk of osteoarthritis, are driving the industry forward. In the worldwide indomethacin injection market, rising knowledge regarding different arthritis therapies in emerging markets is creating important potential possibilities for providers.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/indomethacin-injection-market/

Osteoarthritis Segment to Dominate the Indomethacin Injection Market:
The osteoarthritis segment is expected to account for a larger revenue share in the global Indomethacin Injection market, with a value share of 65.7% worldwide. It is projected to grow at a 6.1% CAGR between 2022 and 2028. As per a study reported in the Lancet Journal in November 2020 by David J Hunter et al., osteoarthritis affected about 7% of the global population, or more than 500 million people, in 2019, with women disproportionately affected. The large of people affected by osteoarthritis globally rose by 48 % from 1990 to 2019, and osteoarthritis was the 15th leading cause of years lived with disability in 2019. (YLDs). Increased public awareness, the availability of better treatment alternatives, and the desire to seek treatment are all likely to contribute to the worldwide osteoarthritis treatment market's growth.

Europe Indomethacin Injection Market:
The Europe market is expected to hold a significant market share in the global indomethacin injection market over the forecast period. It is projected to grow at a CAGR of 5.7% in the coming years. Increasing senior populations in nations such as Germany, Italy, and the United Kingdom are fueling market expansion. Furthermore, the increasing prevalence of obesity among European populations fuels market expansion.

Strategic New Product Launches, Mergers, Acquisitions, and Agreements are the key strategies adopted by market players:
The global Indomethacin Injection market further reveals that the key players are increasingly adopting strategies such as the launch of newer products, product launches, and long-term alliances to improve market revenue share and gain significant geographic presence across the region.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=37913

The indomethacin injection market is segmented based on medical use, distribution channel, and geography.
Based on medical use, the market is segmented into the following:
• Rheumatoid Arthritis
• Ankylosing Spondylitis
• Osteoarthritis
• Gouty Arthritis
• Acute painful shoulder bursitis or tendinitis
• Headaches
• Others

Based on the distribution channel, the market is segmented into the following:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=37913

Key players' profiles in the Indomethacin Injection Market report are Zydus Pharmaceuticals, Inc, Hospira, Inc., Fresenius Kabi Aktiengesellschaft, Recordati S.P.A, and Bedford Laboratories.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.